Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19

Crit Care. 2020 Jun 9;24(1):320. doi: 10.1186/s13054-020-03051-w.

Authors

Akshay Shah¹, Joe N Frost², Louise Aaron³, Killian Donovan³, Hal Drakesmith^{2

4}; Collaborators

Collaborators

Collaborators:
Stuart R McKechnie, Simon J Stanworth

Affiliations

¹ Radcliffe Department of Medicine, University of Oxford and John Radcliffe Hospital, Level 4 Academic Block, Headley Way, Oxford, OX3 9DU, UK. akshay.shah@linacre.ox.ac.uk.
² MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
³ Adult Intensive Care Unit, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
⁴ Haematology Theme, NIHR Oxford Biomedical Research Centre, Oxford, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19
Coronavirus Infections / blood*
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy
Female
Humans
Hypoxia / physiopathology*
Intensive Care Units
Iron / blood*
Male
Middle Aged
Pandemics
Pneumonia, Viral / blood*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy
Respiratory Insufficiency / physiopathology*
Retrospective Studies
Severity of Illness Index

Substances

Iron

Grants and funding

MC_UU_00008/10/MRC_/Medical Research Council/United Kingdom